You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Thyroid cancer is the eighth most common type of cancer and is most frequently diagnosed among people aged 45-54. Nearly three out of four cases are found in women, while about 2% of thyroid cancers occur in children and teenagers. This book is for medical doctors with experience in the field of thyroid cancer. It comprises different subjects, especially the advances in the diagnosis of thyroid cancer with PET imaging and elastography, as well as the new therapeutic approaches with tyrosine kinase inhibitors.
This issue of PET Clinics focuses on Theranostics and is edited by Drs. Ali Gholamrezanezhad and Hojjat Ahmadzadehfar. Articles will include: Good Clinical Practice for Theranostics; Theranostics in Neuroendocrine Tumors; Neuroendocrine Tumors: Imaging Perspective; Prostate Cancer Theranostics: From Target Description to Imaging; Prostate Cancer Theranostics: PSMA-targeted Therapy; Theranostics in Brain Tumors; Theranostics in Neuroblastoma; Theranostics in Thyroid Cancer; and more!
This issue of PET Clinics focuses on Recent Advances in Imaging with PET, CT, and MR Techniques and is edited by Drs. Habib Zaidi, Abass Alavi and Drew A. Torigian. Articles will include: Total-body PET imaging: Developments in instrumentation; Prospects for total-body PET imaging using plastic scintillators; Total-body imaging: Potential clinical applications; New challenges for PET image reconstruction for total-body imaging; Advances in preclinical PET instrumentation; Applications of hybrid PET/MRI in CNS disorders; Applications of hybrid PET-MRI in MSK disorders; Assessment of total body atherosclerosis burden by PET-CT; Recent advances on CT and MR imaging in radiology; Potential impact of Total Body PET imaging in measuring global disease burden in systemic inflammatory disorders; Applications of PET-MRI in CV disorders; and more!
Prostate cancer is diagnosed commonly in the course of general health screening. Very often it is difficult to tell whether the cancer will be aggressive and lethal or will be so slow growing that it will not affect the patient's survival. Treatment can have a major impact on the patient's health-related quality of life. This book presents cutting-edge research in predicting the behavior of localized and metastatic cancer, targeted treatment of cancer that has spread minimally, response to newer methods of treatment, and rehabilitation of patients.
This issue of PET Clinics is Part I of a two-part issue, and focuses on PET-CT-MRI Applications of Musculoskeletal Disorders. It is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Ali Salavati, Ali Gholamrezanezhad and Ali Guermazi. Articles will include: Basic principles, methodology, and imaging protocol for musculoskeletal applications; Sodium 18F-Fluoride PET-CT-MR of bone and joint disorders; In vivo molecular imaging of inflammation and infection; Radionuclide therapy for osseous metastases; Novel whole-body MR imaging techniques in MSK disorders; MRI of joint infection and inflammation with emphasis on DCE-MRI; Quantitative techniques for musculoskeletal MRI at 7 Tesla; Role of contrast enhanced (including iodine overlay image), spectral, and dual energy CT in MSK applications; Percutaneous thermal ablation in musculoskeletal system: Post-procedural PET-CT imaging; Soft tissue sarcomas of Musculoskeletal Origin; Application of PET/CT, PET/MR on primary bone malignancies; Future perspective of the application of PET-CT-MRI in musculoskeletal disorders, and more!
In the new edition of this very successful book, European and North American experts present the state of the art in diagnostic and therapeutic radionuclide procedures. The aim is to examine established and emerging clinical applications in detail, rather than to consider everything included in the comprehensive texts already available within the field. This “practical” approach ensures that the book will be a valuable guide for nuclear medicine physicians, technologists, students, and interested clinicians alike. This edition of Clinical Nuclear Medicine has been extensively revised to take account of recent developments. The roles of SPECT/CT, PET/CT, and PET/MRI are clearly explained and illustrated, and the coverage extended to encompass, for example, novel PET tracers and therapeutic radionuclides, advanced techniques of brain imaging, and the development of theranostics. Readers will be fully persuaded of the ever-increasing value of nuclear medicine techniques in depicting physiology and function and complementing anatomic modalities such as CT, MRI, and ultrasound.
This work has true international scope, being a unique European/American joint venture that focuses on the state of the art in both diagnostic and therapeutic radionuclide methodology. Pertinent clinical applications are emphasized rather than attempting to cover everything included in the several large comprehensive texts available in our field. This "practical" approach should make it an essential guide to nuclear medicine physicians, technologists, students and interested clinicians alike.
This book is the ideal study tool for all who are preparing for national or international nuclear medicine exams and in addition represents a truly outstanding quick review resource. More than 4200 questions, with comprehensive answers, are presented in order to enable readers to assess their knowledge and identify areas of weakness that require further self-study. Informative subchapters permit exploration of specific topics in greater depth, and practice tests will familiarize readers with the process of taking multiple-choice examinations. The book covers the entire spectrum of nuclear medicine, from basic science to clinical applications for diagnosis and treatment. Individual sections focus on oncology, bone and joint disorders, gastrointestinal disorders, acute care, cardiology, neurology and psychiatry, and renal disease. Principles of Nuclear Medicine is highly recommended for those who are taking nuclear medicine or radiology board examinations or recertifying their subspecialty certificate (CAQ) in nuclear medicine. More generally, it will be an asset for all trainees and practitioners of nuclear medicine and radiology.
99mTc-sestamibi is a single-photon emission computed tomography (SPECT) radiotracer that is widely used for the imaging of myocardial perfusion, as well as a variety of malignant and benign diseases. 99mTc-Sestamibi – Clinical Applications provides a detailed and informative overview of almost all the oncologic and non-oncologic applications of 99mTc-sestamibi SPECT, including several relatively rare indications. Different disease-related protocols for 99mTc-sestamibi SPECT are presented, and for each disease a comprehensive summary of the relevant pathology and epidemiology is provided. Throughout, there is a strong emphasis on the practical aspects of use of this popular tracer, including instructions for the preparation of several commercially available tracer kits. Clinical practitioners will find this book to be an invaluable guide to the application and benefits of 99mTc-sestamibi SPECT in both the inpatient and the outpatient setting.
Featuring chapters from specialists in endocrinology, physiology, pathology, and nuclear medicine, this book provides a multidisciplinary approach to a wide variety of issues concerning somatostatin and its analogues. The book: Provides the most up-to-date coverage of somatostatin analog use in diagnostic and therapy Integrating the specialties of endocrinology, physiology, pathology, and nuclear medicine, providing the multidisciplinary approach to the topic Focuses on future applications, novel compounds, and areas for further research Covers topics by authors who are renowned experts and researchers in the field